BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16734908)

  • 1. Intestinal strongyloidiasis and hyperinfection syndrome.
    Vadlamudi RS; Chi DS; Krishnaswamy G
    Clin Mol Allergy; 2006 May; 4():8. PubMed ID: 16734908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Strongyloides stercoralis hyperinfection induced by glucocorticoids a result of both suppressed host immunity and altered parasite genetics?
    Herbert DR; Stoltzfus JDC; Rossi HL; Abraham D
    Mol Biochem Parasitol; 2022 Sep; 251():111511. PubMed ID: 36007683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strongyloides hyperinfection in a patient with solid malignant tumor a case report.
    GeethaBanu S; Arthi K
    Indian J Public Health; 2020; 64(1):90-92. PubMed ID: 32189692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strongyloides stercoralis infection complicating the central nervous system.
    Woll F; Gotuzzo E; Montes M
    Handb Clin Neurol; 2013; 114():229-34. PubMed ID: 23829913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strongyloides Hyperinfection Syndrome: A Curious Case of Asthma Worsened by Systemic Corticosteroids.
    Salam R; Sharaan A; Jackson SM; Solis RA; Zuberi J
    Am J Case Rep; 2020 Dec; 21():e925221. PubMed ID: 33347427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloides stercoralis Infection in Humans: A Narrative Review of the Most Neglected Parasitic Disease.
    Yeh MY; Aggarwal S; Carrig M; Azeem A; Nguyen A; Devries S; Destache C; Nguyen T; Velagapudi M
    Cureus; 2023 Oct; 15(10):e46908. PubMed ID: 37954715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection.
    Reddy TS; Myers JW
    Am J Med Sci; 2003 May; 325(5):288-91. PubMed ID: 12792249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Strongyloides in Solid Organ Transplant Recipients.
    Hayes J; Nellore A
    Infect Dis Clin North Am; 2018 Sep; 32(3):749-763. PubMed ID: 30146034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
    Hennessey DC; Ballesteros ÓA; Merchán DJ; Guevara FO; Severiche DF
    Biomedica; 2020 Jun; 40(2):228-232. PubMed ID: 32673452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strongyloidiasis--an insight into its global prevalence and management.
    Puthiyakunnon S; Boddu S; Li Y; Zhou X; Wang C; Li J; Chen X
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3018. PubMed ID: 25121962
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Luvira V; Siripoon T; Phiboonbanakit D; Somsri K; Watthanakulpanich D; Dekumyoy P
    Trop Med Infect Dis; 2022 Oct; 7(10):. PubMed ID: 36288051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant gastrointestinal hemorrhage due to Strongyloides stercoralis hyperinfection in an AIDS patient.
    Bollela VR; Feliciano C; Teixeira AC; Junqueira AC; Rossi MA
    Rev Soc Bras Med Trop; 2013; 46(1):111-3. PubMed ID: 23563839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strongyloides stercoralis hyperinfection in a patient with AIDS.
    Bava AJ; Troncoso AR
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):235-8. PubMed ID: 19498213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in a case of diffuse alveolar hemorrhage due to Strongyloides stercoralis hyperinfection.
    Steinhaus DA; Gainor JF; Vernovsky I; Winsett J; Beer DJ
    Respir Med Case Rep; 2012; 5():4-5. PubMed ID: 26029582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pyogenes bacteremia and toxic shock syndrome related to Strongyloides stercoralis hyperinfection: a case report.
    Cohen R; Finn T; Babushkin F; Shapiro M; Uda M; Grossman T
    J Med Case Rep; 2018 Nov; 12(1):346. PubMed ID: 30463627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongyloides stercoralis: hyperinfection in immunosuppressed dogs.
    Schad GA; Hellman ME; Muncey DW
    Exp Parasitol; 1984 Jun; 57(3):287-96. PubMed ID: 6723900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.